Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), sold 10,000 shares at $11.76 ($118K) on 2022-06-22, disclosed to the SEC on 2022-06-23.
Open-market sale of $118k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $270K | — | Filing → |